Theravask

Theravask

amlodipine

Manufacturer:

Darya-Varia
Concise Prescribing Info
Contents
Amlodipine besylate
Indications/Uses
Mono- or combination therapy of HTN; 1st-line treatment of myocardial ischaemia due to stable angina &/or Prinzmetal's or variant angina.
Dosage/Direction for Use
HTN & angina Initially 5 mg once daily. Wait 7-14 days to titrate according to BP goals. Max: 10 mg once daily. Small, fragile, elderly, hepatic insufficiency patient 2.5 mg once daily. Chronic stable or vasospastic angina 5-10 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to dihydropyridines.
Special Precautions
Patients w/ severe obstructive CAD or aortic stenosis. Hepatic impairment. No sufficient data for pregnancy & lactation. Childn.
Adverse Reactions
Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitation, dizziness.
ATC Classification
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Theravask tab 5 mg
Packing/Price
3 × 10's (Rp120,450/boks)
Form
Theravask tab 10 mg
Packing/Price
3 × 10's (Rp175,450/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in